The clinicians at Hazelden’s Beaverton clinic understand the literature and science behind opiate addiction and dependence. The current medical literature reveals improved rates of treatment engagement, and recovery when patients are provided the opportunity to extend their detoxification over a period of months. This reflects scientific understanding of the regions of the brain responsible for triggering relapse behavior in patients suffering from addictive disease.

When Hazelden clients choose to extend their detoxification and “maintain” their dependence on opiates to allow a slow, gradual taper of the medication Buprenorphine/naloxone or Suboxone it is important that this treatment occur in a structured environment that maintains the focus on the cognitive and behavioral aspects of recovery.

We understand that change takes time.